Literature DB >> 23793571

Seroprevalence of antibodies against measles, rubella, mumps, varicella-zoster, and B. Pertussis in young adults of Madrid, Spain.

Alba González-Escalada1, Laura García-García, Pablo Viguera-Ester, Patricia Marín-García, Jesus García, Angel Gil-de-Miguel, Ruth Gil-Prieto.   

Abstract

In recent years, there has been an increase in the number of cases of certain immunopreventable diseases in our country. A high proportion of these have been recorded among the young adult population. The aim of this study was to determine the seroprevalence of antibodies against immunopreventable diseases with the greatest health impacts on the young adult population (19-39 y of age) in Madrid. We collected a total of 1,153 serum samples from healthy volunteers undergoing routine medical visits and used ELISA to determine the presence of IgG antibodies against measles, rubella, mumps, and varicella zoster, as well as Bordetella pertussis. The Pearson's χ(2) test was used to compare prevalences, the Mann-Whitney U test was used to compare means, and the Kruskal-Wallis test was applied for variables with more than 2 categories. Statistical significance was achieved with p values of<0.05. The global prevalence of antibodies was 92.1% for measles, 94.4% for rubella, 88.3% for mumps, 92.8% for varicella zoster, and 70.2% for B. pertussis. No statistically significant differences were found between genders. The prevalence of antibodies against measles was more than 95% in the group of individuals born after 1986, and the percentage of individuals susceptible to rubella was less than 5% in women born after 1986. In spite of adequate vaccination coverage, in our region, a population of young adults exists who have not achieved the objectives of the WHO for the elimination of measles and congenital rubella syndrome.

Entities:  

Keywords:  B. Pertussis; Varicela-Zoster Virus; measles; mumps; rubella; seroprevalence; young adults

Mesh:

Substances:

Year:  2013        PMID: 23793571      PMCID: PMC3906357          DOI: 10.4161/hv.25127

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  29 in total

1.  [Epidemiology of varicella in spain pre-and post-vaccination periods].

Authors:  Isabel Peña-Rey; María Victoria Martínez de Aragón; Ana Villaverde Hueso; Monserrat Terres Arellano; Enrique Alcalde Cabero; Berta Suárez Rodríguez
Journal:  Rev Esp Salud Publica       Date:  2009 Sep-Oct

2.  [Evolution of measles, rubella and mumps from the third seroepidemiological survey in the autonomous region of Madrid, Spain].

Authors:  Juan Carlos Sanz Moreno; Luis García Comas; Rosa Ramírez Fernández; Belén Ramos Blázquez; María Ordobás Gavín
Journal:  Rev Esp Salud Publica       Date:  2009 Sep-Oct

3.  [Seroepidemiologic study of rubella in childbearing women in Aragon, Spain (2003-2007)].

Authors:  Rogelio Hernández Díaz; María Pilar Rodrigo Val; Antonio Misiego Peral; María Lourdes Roc Alfaro; María Begoña Adiego Sancho
Journal:  Gac Sanit       Date:  2010-11-12       Impact factor: 2.139

4.  Comparison of fifteen commercial assays for detecting Varicella Zoster virus IgG with reference to a time resolved fluorescence immunoassay (TRFIA) and the performance of two commercial assays for screening sera from immunocompromised individuals.

Authors:  P A Chris Maple; Annabel Gunn; Jane Sellwood; David W G Brown; Jim J Gray
Journal:  J Virol Methods       Date:  2008-11-28       Impact factor: 2.014

5.  The epidemiology of mumps in Italy.

Authors:  G Gabutti; M Guido; M C Rota; A De Donno; M L Ciofi Degli Atti; P Crovari
Journal:  Vaccine       Date:  2008-04-08       Impact factor: 3.641

6.  The utility of seroepidemiology for tracking trends in pertussis infection.

Authors:  H E Quinn; P B McIntyre; J L Backhouse; H F Gidding; J Brotherton; G L Gilbert
Journal:  Epidemiol Infect       Date:  2009-09-01       Impact factor: 2.451

7.  [Seroepidemiologic studies].

Authors:  Neus Cardeñosa Marín
Journal:  Rev Esp Salud Publica       Date:  2009 Sep-Oct

8.  The seroepidemiology of Bordetella pertussis in Israel--Estimate of incidence of infection.

Authors:  Pamela Rendi-Wagner; Joshua Tobias; Larisa Moerman; Sophy Goren; Ravit Bassal; Manfred Green; Dani Cohen
Journal:  Vaccine       Date:  2010-03-10       Impact factor: 3.641

9.  Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis.

Authors:  M Riffelmann; K Thiel; J Schmetz; C H Wirsing von Koenig
Journal:  J Clin Microbiol       Date:  2010-10-13       Impact factor: 5.948

10.  Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets.

Authors:  Anthony Nardone; Annedore Tischer; Nick Andrews; Jo Backhouse; Heidi Theeten; Nina Gatcheva; Marios Zarvou; Bohumir Kriz; Richard G Pebody; Kalman Bartha; Darina O'Flanagan; Dani Cohen; Arnis Duks; Algirdas Griskevicius; Joel Mossong; Christopher Barbara; Adrianna Pistol; Margareta Slaciková; Katarina Prosenc; Kari Johansen; Elizabeth Miller
Journal:  Bull World Health Organ       Date:  2008-02       Impact factor: 9.408

View more
  12 in total

1.  Response to third rubella vaccine dose.

Authors:  Lotta Siira; Hanne Nøkleby; Regine Barlinn; Øystein R Riise; Ingeborg S Aaberge; Susanne G Dudman
Journal:  Hum Vaccin Immunother       Date:  2018-06-21       Impact factor: 3.452

Review 2.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

3.  High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.

Authors:  Michael Hecker; Brit Fitzner; Matthias Wendt; Peter Lorenz; Kristin Flechtner; Felix Steinbeck; Ina Schröder; Hans-Jürgen Thiesen; Uwe Klaus Zettl
Journal:  Mol Cell Proteomics       Date:  2016-02-01       Impact factor: 5.911

4.  Seroprevalence of Varicella zoster virus antibody among young women before marriage in Sanandaj, Iran.

Authors:  Parviz Majidy; Mazaher Khodabandehloo; Nammam-Ali Azadi
Journal:  Iran J Microbiol       Date:  2016-04

5.  Seroprevalence of Bordetella pertussis antibodies in adults in Hungary: results of an epidemiological cross-sectional study.

Authors:  Péter Torzsa; Raghavendra Devadiga; Monica Tafalla
Journal:  BMC Infect Dis       Date:  2017-04-04       Impact factor: 3.090

6.  Sero-epidemiological study in prediction of the risk groups for measles outbreaks in Vojvodina, Serbia.

Authors:  Mioljub Ristić; Vesna Milošević; Snežana Medić; Jelena Djekić Malbaša; Smiljana Rajčević; Jasmina Boban; Vladimir Petrović
Journal:  PLoS One       Date:  2019-05-09       Impact factor: 3.240

7.  Compliance with the guidelines on recommended immunization schedule in patients with inflammatory bowel disease: implications on public health policies.

Authors:  Cristina García-Serrano; Glòria Mirada; Josep R Marsal; Marta Ortega; Joaquim Sol; Rubén Solano; Eva M Artigues; Pepi Estany
Journal:  BMC Public Health       Date:  2020-05-19       Impact factor: 3.295

8.  Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness.

Authors:  Í Ödemiş; Ş Köse; Í Akbulut; H Albayrak
Journal:  Rev Esp Quimioter       Date:  2019-10-23       Impact factor: 1.553

Review 9.  Vaccination of Adult Patients with Systemic Lupus Erythematosus in Portugal.

Authors:  Maria Francisca Moraes-Fontes; Ana Margarida Antunes; Heidi Gruner; Nuno Riso
Journal:  Int J Rheumatol       Date:  2016-03-16

10.  A Serosurvey Identifying Vulnerability to Measles in Health Care Workers. A Hospital-Based Prospective Seroprevalence Study.

Authors:  Jana Malinová; Marek Petráš; Alexander M Čelko
Journal:  Int J Environ Res Public Health       Date:  2020-06-12       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.